Re

Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalEuropean Urology
DOIs
StateAccepted/In press - 2017

Fingerprint

Testicular Neoplasms
Cisplatin
Drug Therapy
Health

ASJC Scopus subject areas

  • Urology

Cite this

@article{9e64a0fc56e54994a60e9791171f86bc,
title = "Re: Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy",
author = "Aditya Bagrodia and Yair Lotan",
year = "2017",
doi = "10.1016/j.eururo.2017.06.017",
language = "English (US)",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",

}

TY - JOUR

T1 - Re

T2 - Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy

AU - Bagrodia, Aditya

AU - Lotan, Yair

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85021225579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021225579&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2017.06.017

DO - 10.1016/j.eururo.2017.06.017

M3 - Article

JO - European Urology

JF - European Urology

SN - 0302-2838

ER -